Clinical Trial Update: Morphine or Fentanyl for Refractory Dyspnea in COPD [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports completed research evaluating morphine or fentanyl for refractory dyspnea in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• FENTANYL (FENTANYL)
• Morphine (morphine)

Snippet

Sponsor: Huib A.M. Kerstjens | Conditions: COPD | Phase 4 | Status: COMPLETED